ARDX INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Ardelyx, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm

A shareholder class action lawsuit has been filed against Ardelyx (NASDAQ: ARDX), alleging the company made materially false and misleading statements regarding its two core drugs, IBSRELA and XPHOZAH. The litigation creates reputational and potential financial risk for Ardelyx, though the article provides no claimed damages, time period, or details on the alleged misstatements.